Combining PCI and CABG: The role of hybrid revascularization

Current Cardiology Reports

Volumn 15, Issue 4, 2013, Pages

  Green, Kelly D ^a   Lynch Jr , Donald R ^a   Chen, Tyffany P ^a   Zhao, David ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CABG; Completion angiography; Coronary artery bypass grafting; Coronary artery disease; Hybrid coronary revascularization; PCI; Percutaneous coronary intervention

Indexed keywords

ARTICLE; BARE METAL STENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERNAL MAMMARY ARTERY; LEFT INTERNAL MAMMARY ARTERY; MORBIDITY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; SAPHENOUS VEIN GRAFT; STERNOTOMY;

EID: 84873724734     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0351-9     Document Type: Article

References (51)

1. Angelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet. 1996;347(9003):757-8. (Pubitemid 26085655)
2. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internalmammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314(1):1-6. (Pubitemid 16183061)
3. Yeung AC, Leon MB, Jain A, et al. Clinical evaluation of the resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries. J Am Coll Cardiol. 2011;57(17):1778-83.
4. Puskas JD, Williams WH, Mahoney EM, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA. 2004;291(15):1841-9. (Pubitemid 38509496)
5. Weisz G, Leon MB, Holmes DR, et al. Five-year follow-up after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2009;53 (17):1488-97.
6. Alfonso F, Perez-Vizcayno M-J, Hernandez R, et al. Sirolimuseluting stents versus bare-metal stents in patients with in-stent restenosis: results of a pooled analysis of two randomized studies. Catheter Cardiovasc Interv. 2008;72(4):459-67.
7. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation. 1995;91(9):2335-44.
8. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111(25):3435-42. (Pubitemid 40923397)
9. Leacche M, Byrne J, Solenkova N, Reagan B, et al. Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE. J Thorac Cardiovasc Surg. 2012;1-10.
10. Bachinsky WB, Abdelsalam M, Boga G, Kiljanek L, Mumtaz M, McCarty C. Comparative study of same sitting hybrid coronary artery revascularization versus off-pump coronary artery bypass in multivessel coronary artery disease. J Interv Cardiol. 2012;25 (5):460-8. doi:10.1111/j.1540-8183.2012.00752.x.
11. Rab ST, Douglas Jr JS, Lyons E, et al. Hybrid coronary revascularization for the treatment of left main coronary stenosis: a feasibility study. Cathet Cardiovasc Interv. 2011;80(2):238-44.
12. Fedakar A, Tasar M, Rabus MB, Alsalehi S, Toker ME, Balkanay M. Hybrid coronary revascularization for the treatment of left main coronary artery disease in high-risk patients. Heart Surg Forum. 2012;15(1):E51-5.
13. Halkos ME, Vassiliades TA, Douglas JS, et al. Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2011;92(5):1695-702.
14. Hu S-S, Xiong H, Zheng Z, et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery disease. Heart Surg Forum. 2012;15(1):E18-22.
15. The BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600-1606.
16. Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-72.
17. Willerson JT. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. Circulation. 1996;94 (6):1194. (Pubitemid 26307237)
18. The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) investigators. N Engl J Med. 1996;335(4):217-225.
19. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294 (19):2446-54. (Pubitemid 41627922)
20. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol. 2003;41(8):1293-304. (Pubitemid 36438990)
21. Mercado N, Wijns W, Serruys PW, et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg. 2005;130(2):512-9. (Pubitemid 41074186)
22. Yan TD, Padang R, Poh C, et al. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg. 2011;141(5):1134-44.
23. Zhao DX, Leacche M, Balaguer JM, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization. J Am Coll Cardiol. 2009;53(3):232-41.
24. Us MH, Basaran M, Yilmaz M, et al. Hybrid coronary revascularization in high-risk patients. Tex Heart Inst J. 2006;33(4):458-62. (Pubitemid 46103517)
25. Umakanthan R, Leacche M, Zhao DX, Gallion AH, Mishra PC, Byrne JG. Hybrid options for treating cardiac disease. Semin Thorac Cardiovasc Surg. 2011;23(4):274-80.
26. Lee M-S, Faxon DP. Revascularization of left main coronary artery disease. Cardiol Rev. 2011;19(4):177-83.
27. Balaguer JM, Umakanthan R, Leacche M, Byrne JG. Minimally invasive cardiac surgery. Curr Probl Surg. 2012;49(9):529-49.
28. Narasimhan S, Srinivas VS, DeRose Jr JJ. Hybrid coronary revascularization. Cardiol Rev. 2011;19(3):101-7.
29. de Canniere D, Jansens JL, Goldschmidt-Clermont P, Barvais L, Decroly P, Stoupel E. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. Am Heart J. 2001;142(4):563-70. (Pubitemid 32900480)
30. Bonatti J, Lehr EJ, Vesely M, et al. Hybrid coronary revascularization- techniques and outcome. Eur Surg. 2011;43(4):198-204.
31. Lloyd CT, Calafiore AM, Wilde P, et al. Integrated left anterior small thoracotomy and angioplasty for coronary artery revascularization. Ann Thorac Surg. 1999;68(3):908-11. discussion 911-2.
32. Lewis BS, Porat E, Halon DA, et al. Same-day combined coronary angioplasty and minimally invasive coronary surgery. Am J Cardiol. 1999;84(10):1246-7. A8. (Pubitemid 29507505)
33. Zenati M, Cohen HA, Griffith BP. Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Sur. 1999;117(3):439-44. discussion 444-6.
34. Wittwer T, Cremer J, Klima U, Wahlers T, Haverich A. Myocardial "hybrid" revascularization: intermediate results of an alternative approach to multivessel coronary artery disease. J Thorac Cardiovasc Sur. 1999;118(4):766-7. (Pubitemid 29474813)
35. Isomura T, Suma H, Horii T, Sato T, Kobashi T, Kanemitsu H. Minimally invasive coronary artery revascularization: off-pump bypass grafting and the hybrid procedure. Ann Thorac Surg. 2000;70(6):2017-22. (Pubitemid 32015301)
36. Presbitero P, Nicolini F, Maiello L, et al. "Hybrid" percutaneous and surgical coronary revascularization: selection criteria from a single-center experience. Ital Heart J. 2001;2(5):363-8. (Pubitemid 32536887)
37. Cisowski M, Morawski W, Drzewiecki J, et al. Integrated minimally invasive direct coronary artery bypass grafting and angioplasty for coronary artery revascularization. Eur J Cardiothorac Surg. 2002;22(2):261-5. (Pubitemid 34831867)
38. Stahl KD, Boyd WD, Vassiliades TA, Karamanoukian HL. Hybrid robotic coronary artery surgery and angioplasty in multivessel coronary artery disease. Ann Thorac Surg. 2002;74(4):S1358-62. (Pubitemid 35176795)
39. Riess F-C, Bader R, Kremer P, et al. Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up. Ann Thorac Surg. 2002;73(6):1849-55. (Pubitemid 34596729)
40. Lee MS, Wilentz JR, Makkar RR, et al. Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. J Invasive Cardiol. 2004;16(8):419-25. (Pubitemid 39095299)
41. Davidavicius G, Van Praet F, Mansour S, et al. Hybrid revascularization strategy: a pilot study on the association of robotically enhanced minimally invasive direct coronary artery bypass surgery and fractional-flow-reserve- guided percutaneous coronary intervention. Circulation. 2005;112(9 Suppl):I317-22. (Pubitemid 41266693)
42. Kiaii B, McClure RS, Kostuk WJ, et al. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest. 2005;128(6):4046-8. (Pubitemid 43062671)
43. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32(17):2125-34.
44. Katz MR, Van Praet F, de Canniere D, et al. Integrated coronary revascularization: percutaneous coronary intervention plus robotic totally endoscopic coronary artery bypass. Circulation. 2006;114(1 Suppl):I473-6. (Pubitemid 44297194)
45. Vassiliades TAJ, Douglas JS, Morris DC, et al. Integrated coronary revascularization with drug-eluting stents: immediate and sevenmonth outcome. J Thorac Cardiovasc Surg. 2006;131(5):956-62.
46. Gilard M, Bezon E, Cornily JC, et al. Same-day combined percutaneous coronary intervention and coronary artery surgery. Cardiology. 2007;108(4):363-7. (Pubitemid 350126485)
47. Kon ZN, Brown EN, Tran R, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg. 2008;135(2):367-75.
48. Bonatti J, Schachner T, Bonaros N, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology. 2008;110(2):92-5. (Pubitemid 351630033)
49. Reicher B, Poston RS, Mehra MR, et al. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J. 2008;155(4):661-7.
50. Holzhey DM, Jacobs S, Mochalski M, et al. Minimally invasive hybrid coronary artery revascularization. Ann Thorac Surg. 2008;86(6):1856-60.
51. Hu S, Li Q, Gao P, et al. Simultaneous hybrid revascularization versus off-pump coronary artery bypass for multivessel coronary artery disease. Ann Thorac Surg. 2011;91(2):432-8.